India’s drug regulator warns on Abbott’s bioresorbable stents

The Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower
Source: Livemint.com (http://www.livemint.com/rss/industry)